ULTRAGENYX PHARMACEUTICAL IN's ticker is RARE and the CUSIP is 90400D108. A total of 220 filers reported holding ULTRAGENYX PHARMACEUTICAL IN in Q3 2021. The put-call ratio across all filers is 1.38 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2022 | $240,000 | -44.3% | 5,789 | -19.9% | 0.15% | -45.0% |
| Q2 2022 | $431,000 | +46.6% | 7,231 | +78.8% | 0.27% | +83.0% |
| Q1 2022 | $294,000 | -25.2% | 4,044 | -13.5% | 0.15% | 0.0% |
| Q4 2021 | $393,000 | -6.9% | 4,677 | 0.0% | 0.15% | -10.9% |
| Q3 2021 | $422,000 | +17.2% | 4,677 | +23.8% | 0.16% | +19.6% |
| Q2 2021 | $360,000 | +7.1% | 3,777 | +27.9% | 0.14% | +0.7% |
| Q1 2021 | $336,000 | – | 2,952 | – | 0.14% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| First Light Asset Management, LLC | 437,512 | $31,772,000 | 2.80% |
| RTW INVESTMENTS, LP | 1,373,284 | $99,728,000 | 2.06% |
| Rock Springs Capital Management LP | 1,028,109 | $74,661,000 | 1.88% |
| Privium Fund Management B.V. | 112,727 | $8,186,000 | 1.81% |
| Avidity Partners Management LP | 869,000 | $63,107,000 | 1.31% |
| SUVRETTA CAPITAL MANAGEMENT, LLC | 525,100 | $38,133,000 | 1.16% |
| Boxer Capital, LLC | 200,000 | $14,524,000 | 0.75% |
| SECTOR GAMMA AS | 46,221 | $3,357,000 | 0.73% |
| FEDERATED HERMES, INC. | 3,987,728 | $289,589,000 | 0.65% |
| EMERALD ADVISERS, LLC | 223,952 | $16,263,000 | 0.62% |